DARA BioSciences, Inc. Establishes Vertically Integrated Commercial Platform for Specialty Oncology Care and Support Products
Published: Sep 25, 2012
RALEIGH, N.C.--(BUSINESS WIRE)--DARA BioSciences, Inc. (NASDAQ: DARA), a specialty pharmaceutical company focused on oncology and oncology support products, announced today it has a completed a series of agreements with a number of specialty pharmacy providers, leading group purchasing organizations (GPOs), retail partners, reimbursement experts, and an industry-leading third-party logistics provider. DARA believes these agreements provide the company comprehensive commercial coverage across the national oncology market.